# Treat-to-target by Email During Urate-lowering Therapy in Gout

> **NCT04733079** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 204 (estimated)

## Conditions studied

- Gout
- Inflammatory Rheumatism
- Hyperuricemia
- Posology Adjustment

## Interventions

- **OTHER:** Cleanweb electronic messaging ePro
- **OTHER:** Usual follow-up

## Key facts

- **NCT ID:** NCT04733079
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-12-15
- **Primary completion:** 2026-04-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 204 (ESTIMATED)
- **Last updated:** 2026-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04733079

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04733079, "Treat-to-target by Email During Urate-lowering Therapy in Gout". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT04733079. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*